Literature DB >> 4031028

Improved utility of Gonoscreen, a Limulus amoebocyte lysate assay, in the evaluation of urethral discharges in men.

R B Prior, V A Spagna.   

Abstract

The Limulus amoebocyte lysate (LAL) assay was improved for the rapid evaluation of exudative urethritis in males. Two hundred men with various quantities of urethral discharge were evaluated. Pyrogen-free Dacron swabs were used for sample collection, and a chromogenic substrate was used for visible endpoint determination after a 10-min incubation. Of the 200 patients studied, 57 (29%) had minimal urethral discharges (less than 15 microliter) and could not be evaluated with Gonoscreen (Mallinckrodt, Inc., St. Louis, Mo.), an LAL test kit for the evaluation of urethritis which involves gentle aspiration for sample collection. The improved LAL assay had a sensitivity and specificity of 95 and 97%, respectively, and an overall accuracy to predict culture results of 96%. These results were not statistically different from Gram-stained smears read by experienced microscopists or from culture results (P greater than 0.05). Prevalence of gonorrhea in the study population was 40%, and the positive predictive value of the LAL assay was 95%. Thus, the use of swabs facilitated sample collection and increased by 29% the number of patients which could be evaluated with the LAL assay. In addition, the use of a chromogenic substrate reduced incubation time by 67% (30 to 10 min) and provided an objective color endpoint.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031028      PMCID: PMC268346          DOI: 10.1128/jcm.22.2.141-144.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Semiquantitation of urethral polymorphonuclear leukocytes as objective evidence of nongonococcal urethritis.

Authors:  S J Kraus
Journal:  Sex Transm Dis       Date:  1982 Jan-Mar       Impact factor: 2.830

2.  Rapid presumptive diagnosis of gonococcal urethritis in males: evaluation of a prototype limulus lysate test kit.

Authors:  R Nachum; R O Christiansen
Journal:  Med Lab Sci       Date:  1982-01

3.  The Limulus amebocyte lysate assay.

Authors:  V A Spagna; R B Prior
Journal:  Am Fam Physician       Date:  1980-09       Impact factor: 3.292

4.  Lack of utility of a Limulus amoebocyte lysate assay in the diagnosis of urethral discharges in men.

Authors:  F N Judson; B A Werness; M R Shahan
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

5.  Application of a Limulus test device in rapid evaluation of gonococcal and nongonococcal urethritis in males.

Authors:  R B Prior; V A Spagna
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

6.  Evaluation of the limulus amebocyte lysate assay for presumptive diagnosis of gonorrhea in men at a clinic for sexually transmitted diseases.

Authors:  T A Chapel; M Adcock; B Smith; T Barnes; M Goodman
Journal:  Sex Transm Dis       Date:  1981 Jul-Sep       Impact factor: 2.830

7.  Response of several Limulus amoebocyte lysates to native endotoxin present in gonococcal and nongonococcal urethral exudates from human males.

Authors:  R B Prior; V A Spagna
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

8.  Factors affecting the performance of smear and culture tests for the detection of Neisseria gonorrhoeae.

Authors:  M E Goodhart; J Ogden; A A Zaidi; S J Kraus
Journal:  Sex Transm Dis       Date:  1982 Apr-Jun       Impact factor: 2.830

9.  Rapid evaluation of gonococcal and nongonococcal urethritis in men with Limulus amoebocyte lysate and a chromogenic substrate.

Authors:  R B Prior; V A Spagna
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

Review 10.  Gonococcal infections.

Authors:  E W Hook; K K Holmes
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  1 in total

1.  Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.

Authors:  R I Roth; R Yamasaki; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.